NASDAQ
Treace Medical Concepts, Inc. (TMCI)
♥ 346 Thanks from members
Treace Medical Concepts, Inc. (TMCI) demonstrated disciplined cash management and narrower net losses in Q2 2026 despite a slight 4% year-over-year revenue decline, prompting an increased full-year outlook and positive analyst price target adjustments.